<DOC>
	<DOC>NCT02595853</DOC>
	<brief_summary>Hemospray™ is a new endoscopic hemostatic powder. Aims of this multicenter prospective study is to determine effectiveness of Hemospray™ on short and medium term in different clinical situations, predictive factors of rebleeding after Hemospray™ application, and feasibility of the application of hemostatic powder in routine clinical practice studying in a large sample of patients.</brief_summary>
	<brief_title>Efficacy of a Novel Hemostatic Powder in GI Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Male or female aged 18 and over who need the use of Hemospray® under their care in an emergency. Upper gastrointestinal hemorrhage. Patients who received the information note of the study and agreeing to participate (nonoral opposition gathered in the patient's medical record) Non Patient under guardianship, curatorship. Pregnant woman.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Upper GastroIntestinal bleeding, endoscopy, Hemospray</keyword>
</DOC>